The U.S. Food and Drug Administration has approved Axsome Therapeutics' migraine treatment, the company said on Thursday.

NEW YORK - Axsome Therapeutics, Inc. (NASDAQ:AXSM), a $5.28 billion biopharmaceutical company with impressive 51% revenue growth over the last twelve months, announced the U.S. Food and Drug Administration (FDA) has approved SYMBRAVO®,

The oversight could result in “death,” at least for those with a milk allergy or sensitivity, says the FDA. FDA initiated the recall on Dec. 13 and announced three days later that it was recalling the chips due to a potential or undeclared allergen. At present, no allergic reactions have been reported.

STATEN ISLAND, N.Y. — A December 2024 chocolate recall has been upgraded to highest risk level by the U.S. Food and Drug Administration (FDA), which says consuming the product could “cause serious adverse health consequences or death.”

In the midst of a flurry of ongoing food recalls, the FDA has updated its initial recall of a handful of Cal Yee Farms' chocolate products to the highest risk level. Originally, the FDA announced a recall of numerous Cal Yee Farm products because they may have contained undeclared milk,